BioPharm International Supplements, September 2011 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International Supplements, September 2011
Features
Q&A with Francis S. Collins
By Angie Drakulich
Inside the National Institutes of Health
Navigating the Biosimilars Market
By Alan Sheppard
The market landscape for biosimilars is in flux, with limited penetration now, but with the potential for growth for those who can navigate the market. Plus: A SWOT analysis of biosimilars by Anjan Selz.
Perception and Costs of Biotech Innovation
By Ameet Malik
The lower price of biosimilars will increase patient access to medicines and spur innovation.
Trends in Prefills
By Fedra Pavlou
An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.
Challenges and Innovations with Prefilled Syringes
By Raul Soikes
Market considerations and new technologies must be recognized to achieve the full benefits of manufacturing prefilled syringes.
Single-use Technology: Balancing the Risks and Rewards
By Jerold Martin
Developing a quality agreement template for single-use systems.

ADVERTISEMENT

ADVERTISEMENT

Click here